Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-Intron Plus REBETOL in Pediatric Chronic Hepatitis C
NCT00104052Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2005
- Primary completion
- Nov 2007
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
01
Overview
A Phase 3 trial of peginterferon alfa-2b in hepatitis C (HCV), sponsored by Merck & Co.. Started Feb 2005; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00104052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104052.